Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.
Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check5 days agoChange DetectedA new Locations section has been added, listing the participating sites by state (Arizona, California, Indiana, Maryland, Pennsylvania, Virginia). The page revision shows an update to v3.3.3.SummaryDifference0.8%
- Check12 days agoChange DetectedMinor UI/layout adjustments observed between the two screenshots; core study details such as eligibility criteria, locations, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and layout appear consistent with the study record.SummaryDifference0.1%
- Check34 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check41 days agoChange DetectedRemoved the government funding status banner, a general operational notice that previously informed users about site outages and up-to-date status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check48 days agoChange DetectedNo substantive changes detected in the page content; the study details and sections such as Study Overview, Eligibility Criteria, and Study Plan appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.